Further studies indicated that butyrate administration can prevent and ameliorate the development of T2DM by promoting energy expenditure and improving mitochondrial functions [16], and G protein-coupled receptor 43 (GPR43) and glucose transporter 2 (GLUT-2) may play a role in this process [17]. Here, FFAR2 is linked to type 2 diabetes mellitus.